Search results
Results from the WOW.Com Content Network
Bain Capital, LP is an American private investment firm based in Boston, Massachusetts, with around $185 billion of assets under management. [4] It specializes in private equity, venture capital, credit, public equity, impact investing, life sciences, crypto, tech opportunities, partnership opportunities, special situations, and real estate.
India's Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and Bain Capital to raise up to $1.5 billion to bid for India's Cipla, according to three sources with ...
Since 2016, Piramal Enterprises and Bain Capital Credit have been operating a partnership called India Resurgence Fund (IndiaRF), an investment fund for financially distressed Indian companies. [24] Piramal Capital Fund (PCF), a partnership between Piramal Enterprises and CDPQ that was started in 2020, provides corporate financing services. [25]
Bain Capital Ventures LLC is the venture capital division within Bain Capital, which has approximately $160 billion of assets under management worldwide. The firm's early-stage investments have included Attentive, Bloomreach, Billtrust, [ 1 ] Docusign , Flywire, LinkedIn , Justworks, [ 2 ] Turbonomic , [ 3 ] Rent the Runway , [ 4 ] Twilio, [ 5 ...
Bain Capital's proposal values each American depositary share of Chindata at $8, representing a premium of more than 27% to its last closing price. The private equity firm already owns a 42.2% ...
Irving Place Capital (fka BSMB) New York New York: 1965 1997 1976 2008 BNP Paribas: PAI Partners. BNP Paribas Développement. Paris. Paris. 1993 2016 1998 - BT Alex. Brown ^ ABS Capital: Baltimore: 1990 1995 CIBC World Markets: Trimaran Capital Partners: New York: 1995 2001 Citigroup: Court Square Capital Partners CVC Capital Partners Welsh ...
In 2014, Blackstone sold its 13% stake in Emcure to Bain Capital. [16] In 2021, Emcure demerged its US-based business, including subsidiary Heritage Pharmaceuticals, into a new company called Avet Lifesciences. [1] In 2024, Emcure launched its initial public offering, and listed on NSE and BSE. [17]
Investors pushed Bain Capital to almost halve the valuation it was seeking for Japan's Kioxia in an IPO, leading the U.S. buyout firm to scrap its plans for an October listing of the memory ...